| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 07:40:42 UTC |
|---|
| Update Date | 2021-09-26 23:02:08 UTC |
|---|
| HMDB ID | HMDB0250586 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)- |
|---|
| Description | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)- belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Based on a literature review very few articles have been published on L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-. This compound has been identified in human blood as reported by (PMID: 31557052 ). L-prolinamide, n-methyl-l-alanyl-(2s)-2-cyclohexylglycyl-n-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CNC(C)C(=O)NC(C1CCCCC1)C(=O)N1CCCC1C(=O)NC1=C(N=C(S1)C1=NC=CO1)C1=CC=CC=C1 InChI=1S/C29H36N6O4S/c1-18(30-2)24(36)32-23(20-12-7-4-8-13-20)29(38)35-16-9-14-21(35)25(37)34-27-22(19-10-5-3-6-11-19)33-28(40-27)26-31-15-17-39-26/h3,5-6,10-11,15,17-18,20-21,23,30H,4,7-9,12-14,16H2,1-2H3,(H,32,36)(H,34,37) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C29H36N6O4S |
|---|
| Average Molecular Weight | 564.71 |
|---|
| Monoisotopic Molecular Weight | 564.251874837 |
|---|
| IUPAC Name | 1-{2-cyclohexyl-2-[2-(methylamino)propanamido]acetyl}-N-[2-(1,3-oxazol-2-yl)-4-phenyl-1,3-thiazol-5-yl]pyrrolidine-2-carboxamide |
|---|
| Traditional Name | 1-{2-cyclohexyl-2-[2-(methylamino)propanamido]acetyl}-N-[2-(1,3-oxazol-2-yl)-4-phenyl-1,3-thiazol-5-yl]pyrrolidine-2-carboxamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CNC(C)C(=O)NC(C1CCCCC1)C(=O)N1CCCC1C(=O)NC1=C(N=C(S1)C1=NC=CO1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C29H36N6O4S/c1-18(30-2)24(36)32-23(20-12-7-4-8-13-20)29(38)35-16-9-14-21(35)25(37)34-27-22(19-10-5-3-6-11-19)33-28(40-27)26-31-15-17-39-26/h3,5-6,10-11,15,17-18,20-21,23,30H,4,7-9,12-14,16H2,1-2H3,(H,32,36)(H,34,37) |
|---|
| InChI Key | HSHPBORBOJIXSQ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Oligopeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-oligopeptide
- Proline or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alanine or derivatives
- Alpha-amino acid or derivatives
- N-substituted-alpha-amino acid
- N-arylamide
- Pyrrolidine-2-carboxamide
- Pyrrolidine carboxylic acid or derivatives
- N-acylpyrrolidine
- 2,4,5-trisubstituted 1,3-thiazole
- Benzenoid
- Monocyclic benzene moiety
- Heteroaromatic compound
- Thiazole
- Tertiary carboxylic acid amide
- Pyrrolidine
- Oxazole
- Azole
- Secondary carboxylic acid amide
- Carboxamide group
- Amino acid or derivatives
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Secondary aliphatic amine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 228.888 | 30932474 | | DeepCCS | [M-H]- | 226.493 | 30932474 | | DeepCCS | [M-2H]- | 259.376 | 30932474 | | DeepCCS | [M+Na]+ | 235.426 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 15.8938 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.4 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3077.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 203.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 235.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 176.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 253.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 594.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 749.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 229.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1480.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 577.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1786.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 372.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 461.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 196.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 171.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #1 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)N(C)[Si](C)(C)C | 4694.9 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #1 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)N(C)[Si](C)(C)C | 4142.4 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #1 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)N(C)[Si](C)(C)C | 6363.2 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #2 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C | 4481.8 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #2 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C | 3990.4 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #2 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C | 6248.6 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #3 | CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1 | 4517.5 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #3 | CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1 | 3980.0 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TMS,isomer #3 | CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1 | 6160.0 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C)N(C)[Si](C)(C)C | 4494.3 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C)N(C)[Si](C)(C)C | 4150.1 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C)N(C)[Si](C)(C)C | 5999.3 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #2 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)N(C)[Si](C)(C)C | 4542.7 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #2 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)N(C)[Si](C)(C)C | 4148.5 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #2 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)N(C)[Si](C)(C)C | 5891.0 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #3 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)[Si](C)(C)C | 4396.1 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #3 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)[Si](C)(C)C | 4010.4 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TMS,isomer #3 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)[Si](C)(C)C | 5770.7 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,3TMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)[Si](C)(C)C)N(C)[Si](C)(C)C | 4437.3 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,3TMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)[Si](C)(C)C)N(C)[Si](C)(C)C | 4174.1 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,3TMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C)C1CCCCC1)[Si](C)(C)C)N(C)[Si](C)(C)C | 5526.8 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #1 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)N(C)[Si](C)(C)C(C)(C)C | 4896.5 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #1 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)N(C)[Si](C)(C)C(C)(C)C | 4285.2 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #1 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)N(C)[Si](C)(C)C(C)(C)C | 6385.8 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #2 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C(C)(C)C | 4703.2 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #2 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C(C)(C)C | 4131.2 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #2 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C(C)(C)C | 6246.7 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #3 | CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1 | 4737.3 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #3 | CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1 | 4122.8 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,1TBDMS,isomer #3 | CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1 | 6149.4 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C(C)(C)C)N(C)[Si](C)(C)C(C)(C)C | 4900.9 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C(C)(C)C)N(C)[Si](C)(C)C(C)(C)C | 4430.2 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #1 | CC(C(=O)N(C(C(=O)N1CCCC1C(=O)NC1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)C1CCCCC1)[Si](C)(C)C(C)(C)C)N(C)[Si](C)(C)C(C)(C)C | 6016.8 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #2 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1)N(C)[Si](C)(C)C(C)(C)C | 4943.4 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #2 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1)N(C)[Si](C)(C)C(C)(C)C | 4430.8 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #2 | CC(C(=O)NC(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1)N(C)[Si](C)(C)C(C)(C)C | 5895.8 | Standard polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #3 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1)[Si](C)(C)C(C)(C)C | 4772.5 | Semi standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #3 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1)[Si](C)(C)C(C)(C)C | 4279.3 | Standard non polar | 33892256 | | L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-,2TBDMS,isomer #3 | CNC(C)C(=O)N(C(C(=O)N1CCCC1C(=O)N(C1=C(C2=CC=CC=C2)N=C(C2=NC=CO2)S1)[Si](C)(C)C(C)(C)C)C1CCCCC1)[Si](C)(C)C(C)(C)C | 5760.6 | Standard polar | 33892256 |
|
|---|